Filed: 8/14/2024ACC: 0000950123-24-008688
📋 What this filing means
BELLEVUE GROUP AG filed this quarterly 13F‑HR report disclosing 166 equity positions with a total reported market value of $6.15B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
166
Positions
$6.15B
Total AUM (reported)
152.59M
Total Shares
Allocation by class
COM$4.79B77.8%
COM NEW$527.31M8.6%
SPONSORED ADR$304.48M4.9%
CL A$114.29M1.9%
SHS$99.88M1.6%
COM PAR $.01$68.45M1.1%
SPONSORED ADS$55.27M0.9%
Portfolio Concentration
Top 3$969.39M15.8%
4–10$1.49B24.2%
11–25$1.62B26.4%
Rest$2.07B33.7%
Top 3 weight
15.8%
Top 10 weight
40.0%
Voting Authority Distribution
Total shares with voting rights: 152.59M
Sole
Full voting authority
152.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other166
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings166
Rows:
IONIS PHARMACEUTICALS INC
DFNDShares8.26M
TypeSH
Market value$393.69M
6.40%
Sole
8.26M
Shared
0.00
None
0.00
ARGENX SE
DFNDShares691.87K
TypeSH
Market value$297.53M
4.83%
Sole
691.87K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
DFNDShares593.46K
TypeSH
Market value$278.17M
4.52%
Sole
593.46K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
DFNDShares1.90M
TypeSH
Market value$261.39M
4.25%
Sole
1.90M
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
DFNDShares539.90K
TypeSH
Market value$240.18M
3.90%
Sole
539.90K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
DFNDShares919.83K
TypeSH
Market value$223.52M
3.63%
Sole
919.83K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
DFNDShares2.57M
TypeSH
Market value$197.88M
3.22%
Sole
2.57M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
DFNDShares5.03M
TypeSH
Market value$195.18M
3.17%
Sole
5.03M
Shared
0.00
None
0.00
STRYKER CORPORATION
DFNDShares545.93K
TypeSH
Market value$185.75M
3.02%
Sole
545.93K
Shared
0.00
None
0.00
MODERNA INC
DFNDShares1.56M
TypeSH
Market value$185.69M
3.02%
Sole
1.56M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
DFNDShares2.47M
TypeSH
Market value$169.26M
2.75%
Sole
2.47M
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
DFNDShares3.88M
TypeSH
Market value$167.29M
2.72%
Sole
3.88M
Shared
0.00
None
0.00
ABBOTT LABS
DFNDShares1.61M
TypeSH
Market value$166.90M
2.71%
Sole
1.61M
Shared
0.00
None
0.00
DEXCOM INC
DFNDShares1.27M
TypeSH
Market value$143.84M
2.34%
Sole
1.27M
Shared
0.00
None
0.00
INCYTE CORP
DFNDShares2.15M
TypeSH
Market value$130.55M
2.12%
Sole
2.15M
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
DFNDShares1.26M
TypeSH
Market value$116.43M
1.89%
Sole
1.26M
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
DFNDShares2.97M
TypeSH
Market value$109.98M
1.79%
Sole
2.97M
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
DFNDShares205.68K
TypeSH
Market value$104.74M
1.70%
Sole
205.68K
Shared
0.00
None
0.00
INSULET CORP
DFNDShares435.42K
TypeSH
Market value$87.87M
1.43%
Sole
435.42K
Shared
0.00
None
0.00
BECTON DICKINSON & CO
DFNDShares347.33K
TypeSH
Market value$81.18M
1.32%
Sole
347.33K
Shared
0.00
None
0.00
MEDTRONIC PLC
DFNDShares1M
TypeSH
Market value$78.85M
1.28%
Sole
1M
Shared
0.00
None
0.00
BIOHAVEN LTD
DFNDShares2.04M
TypeSH
Market value$70.84M
1.15%
Sole
2.04M
Shared
0.00
None
0.00
INSMED INC
DFNDShares1.02M
TypeSH
Market value$68.45M
1.11%
Sole
1.02M
Shared
0.00
None
0.00
ARVINAS INC
DFNDShares2.39M
TypeSH
Market value$63.64M
1.03%
Sole
2.39M
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
DFNDShares1.54M
TypeSH
Market value$62.18M
1.01%
Sole
1.54M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IONIS PHARMACEUTICALS INCDFND | COM | 8.26M | SH | $393.69M 6.40% | 8.26M | 0.00 | 0.00 |
ARGENX SEDFND | SPONSORED ADR | 691.87K | SH | $297.53M 4.83% | 691.87K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCDFND | COM | 593.46K | SH | $278.17M 4.52% | 593.46K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCDFND | COM | 1.90M | SH | $261.39M 4.25% | 1.90M | 0.00 | 0.00 |
INTUITIVE SURGICAL INCDFND | COM NEW | 539.90K | SH | $240.18M 3.90% | 539.90K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCDFND | COM | 919.83K | SH | $223.52M 3.63% | 919.83K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPDFND | COM | 2.57M | SH | $197.88M 3.22% | 2.57M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 5.03M | SH | $195.18M 3.17% | 5.03M | 0.00 | 0.00 |
STRYKER CORPORATIONDFND | COM | 545.93K | SH | $185.75M 3.02% | 545.93K | 0.00 | 0.00 |
MODERNA INCDFND | COM | 1.56M | SH | $185.69M 3.02% | 1.56M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCDFND | COM | 2.47M | SH | $169.26M 2.75% | 2.47M | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCDFND | COM | 3.88M | SH | $167.29M 2.72% | 3.88M | 0.00 | 0.00 |
ABBOTT LABSDFND | COM | 1.61M | SH | $166.90M 2.71% | 1.61M | 0.00 | 0.00 |
DEXCOM INCDFND | COM | 1.27M | SH | $143.84M 2.34% | 1.27M | 0.00 | 0.00 |
INCYTE CORPDFND | COM | 2.15M | SH | $130.55M 2.12% | 2.15M | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPDFND | COM | 1.26M | SH | $116.43M 1.89% | 1.26M | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWDFND | COM NEW | 2.97M | SH | $109.98M 1.79% | 2.97M | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCDFND | COM | 205.68K | SH | $104.74M 1.70% | 205.68K | 0.00 | 0.00 |
INSULET CORPDFND | COM | 435.42K | SH | $87.87M 1.43% | 435.42K | 0.00 | 0.00 |
BECTON DICKINSON & CODFND | COM | 347.33K | SH | $81.18M 1.32% | 347.33K | 0.00 | 0.00 |
MEDTRONIC PLCDFND | SHS | 1M | SH | $78.85M 1.28% | 1M | 0.00 | 0.00 |
BIOHAVEN LTDDFND | COM | 2.04M | SH | $70.84M 1.15% | 2.04M | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 1.02M | SH | $68.45M 1.11% | 1.02M | 0.00 | 0.00 |
ARVINAS INCDFND | COM | 2.39M | SH | $63.64M 1.03% | 2.39M | 0.00 | 0.00 |
TANDEM DIABETES CARE INCDFND | COM NEW | 1.54M | SH | $62.18M 1.01% | 1.54M | 0.00 | 0.00 |
Page 1 of 7
…